Diseases of Pulmonary Vasculature

Latest Features

Pulmonary Arterial Hypertension and Genetics: Interview With the Experts

Pulmonary Arterial Hypertension and Genetics: Interview With the Experts

James E. Loyd, MD, and Wendy Chung, MD, PhD, offer insight into the role of genetics in pulmonary arterial hypertension.

Latest News

Coronary Artery Disease-Related Death Increased With Opioid Use in COPD

Coronary Artery Disease-Related Death Increased With Opioid Use in COPD

Opioid use increases cardiac event risk in older adults with chronic obstructive pulmonary disease.

Pulmonary Artery-to-Aorta Ratio May Predict Survival in Idiopathic Pulmonary Fibrosis

Pulmonary Artery-to-Aorta Ratio May Predict Survival in Idiopathic Pulmonary Fibrosis

Pulmonary artery to aorta ratio measurement can effectively predict survival in patients with idiopathic pulmonary fibrosis.

Sarcoidosis-Associated Pulmonary Hypertension: Predicting Factors for Reduced 6MWD

Sarcoidosis-Associated Pulmonary Hypertension: Predicting Factors for Reduced 6MWD

Multiple factors have influenced a 6-minute reduction in sarcoidosis-associated pulmonary hypertension.

Peripheral Artery Disease-Related Leg Ischemia and Antihypertensive Use

Peripheral Artery Disease-Related Leg Ischemia and Antihypertensive Use

Mean arterial pressure in patients with peripheral artery disease decreased as a result of antihypertensive medication.

Biomarkers Linking SLE-Associated Pulmonary Arterial Hypertension

Biomarkers Linking SLE-Associated Pulmonary Arterial Hypertension

Mortality rates in SLE-associated pulmonary arterial hypertension are higher compared to the general SLE population even-though diagnostic and treatment strategy have improved in the last 50 years.

Aterial Stiffness May Be Predicted by Restrictive Spirometry Pattern

Aterial Stiffness May Be Predicted by Restrictive Spirometry Pattern

Restrictive spirometry pattern and reduced forced vital capacity (FVC) are associated with a higher risk for arterial stiffness regardless of sex.

Reducing Amputation Risk in Diabetes With Peripheral Artery Disease

Reducing Amputation Risk in Diabetes With Peripheral Artery Disease

Researchers examined statin therapy as a method of risk reduction in lower extremity amputation.

Right Upper Extremity Deep Vein Thrombosis: A Case Study

Right Upper Extremity Deep Vein Thrombosis: A Case Study

A case study of a patient presented to the emergency room for right upper extremity deep vein thrombosis after rib resection and subclavian vein stent placement 15 years ago.

Venous Thromboembolism and Sepsis Risks Increase With Short-Term Oral Corticosteriods

Venous Thromboembolism and Sepsis Risks Increase With Short-Term Oral Corticosteriods

An increased risk of sepsis, venous thromboembolism and fracture was linked to short term use of oral corticosteroids.

Cardiovascular Risks Not Increased With Long-Acting Beta2-Agonist for COPD

Cardiovascular Risks Not Increased With Long-Acting Beta2-Agonist for COPD

Combination therapy with an inhaled long-acting beta2-agonist and an inhaled corticosteroid did not affect all-cause mortality compared with inhaled placebo.

VTE Recurrence Risk Reduced With Rivaroxaban: Q&A With EINSTEIN CHOICE Investigator

VTE Recurrence Risk Reduced With Rivaroxaban: Q&A With EINSTEIN CHOICE Investigator

Results from the EINSTEIN CHOICE trial plus an interview with investigator Philip Stephen Wells, MD, FRCP(C), MSc.

Surgical Pulmonary Embolectomy Outcomes Not Affected by Thrombus Location

Surgical Pulmonary Embolectomy Outcomes Not Affected by Thrombus Location

Survival rates were high for patients with both central and peripheral pulmonary emboli.

Statin Use May Reduce Mortality in COPD Patients

Statin Use May Reduce Mortality in COPD Patients

While data are conflicting, statin use in COPD may help reduce pulmonary-related and all-cause mortality.

Intracerebral Hemorrhage: Trends in Medical Complications

Intracerebral Hemorrhage: Trends in Medical Complications

After intracerebral hemorrhage, both acute renal failure and deep venous thrombosis have increased.

How Does Pulmonary Embolism Risk Compare After CVT vs DVT?

How Does Pulmonary Embolism Risk Compare After CVT vs DVT?

Pulmonary embolism risk after cerebral venous thromboembolism is significantly lower than after deep vein thromboembolism.

Venous Thromboembolism Risk Increased With Giant Cell Arteritis

Venous Thromboembolism Risk Increased With Giant Cell Arteritis

Patients with giant cell arteritis were more likely to experience venous thromboembolism during the first 3 months following diagnosis.

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension Treatments

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension Treatments

Initial combination therapy with ambrisentan and tadalafil reduced the risk for first clinical failure event in patients with connective tissue disease-associated pulmonary arterial hypertension.

Resistant Hypertension May Increase Sleep Apnea Risk

Resistant Hypertension May Increase Sleep Apnea Risk

Patients with resistant hypertension had a modest increase in risk of developing sleep apnea compared to those with nonresistant hypertension.

New Metabolites Associated With Hemodynamic Indicators of Right Ventricular-Pulmonary Vascular Dysfunction Discovered

New Metabolites Associated With Hemodynamic Indicators of Right Ventricular-Pulmonary Vascular Dysfunction Discovered

Researchers discovered 21 new metabolites associated with 2 or more hemodynamic indicators of right ventricular-pulmonary vascular function.

Treatment and Length of Stay Changes Reduce Pulmonary Embolism Mortality

Treatment and Length of Stay Changes Reduce Pulmonary Embolism Mortality

RIETE registry reveals an association between improved hospital care and reduced pulmonary embolism mortality.

Sign Up for Free e-Newsletters